Clasado expands EU market presence with NUTRAGROUP distribution deal

Clasado Biosciences ('Clasado'), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has strengthened the European presence through a new distribution agreement with French ingredient specialist, NUTRAGROUP.

The new agreement will see award-winning prebiotic galactooligosaccharide (GOS) ingredient, Bimuno®, available to health and wellbeing formulators in the French market. 

The most studied prebiotic of its kind, Bimuno is supported by over 100 scientific publications, including more than 20 clinical trials. Establishing its ingredient in the global market, Clasado has increased its geographic reach with expansion into regions such as North America, Asia, EMEA, Australia and New Zealand.

Per Rehné, CEO of Clasado, explains the significance of the new agreement: “Europe is one of the largest markets for prebiotics and according to research firm Mordor Intelligence, the category is set to grow at a very robust 7.11% CAGR to 2025 in Europe, so it’s clear to see that demand is still surging.

“We are continuing to transition from an exclusively science-focused business to one that makes the science commercially available and accessible. NUTRAGROUP is a highly established leader in the health & nutrition market, with a strong presence. We look forward to seeing Bimuno make its mark in the region.”

With gut health continuing to drive the consumer health agenda, Bimuno is designed to make complex microbiome science simple and easy to understand. The ingredient nourishes bifidobacteria, a beneficial bacterium in the gut that is understood to impact key areas of health, including digestive health, mental health, cognition and immune function.

The ingredient has been developed with versatility front of mind and is available in powder or syrup form. Bimuno is highly stable under a wide range of heat and acidities, making it suitable for a broad range of applications, such as standalone supplements, including powders and gummies, as well as functional food applications.

Kevin Wilson, Business Development Director at NUTRAGROUP, adds: “In today’s market, consumer demand is king. With better gut health high on the agenda, we’re proud to add Bimuno to our ingredient range. Despite some of the strongest scientific backing for a prebiotic in the sector, it remains remarkably simple for formulators to use, with a low effective dose and stability that means it can be added to formulations at any point in the manufacturing process.

“France, like the wider European market, is acknowledging the potential of prebiotics - the time for formulators and nutrition brands to embrace the benefits is now. With Bimuno, the path forward is clear for businesses looking to connect with an engaged and proactive health audience.

To find out more about Clasado Biosciences, please visit www.clasado.com